Urging the Congress of the United States to establish policies that would provide greater access to blood transfusions for hospice patients with blood cancer.
Impact
The bill, if supported at the federal level, would necessitate changes in how Medicare reimburses hospice providers for blood transfusions by allowing for separate payment models. Currently, the per diem structure fails to adequately cover the costs of transfusions, which can reach an average of $2,388 per unit. Given that many patients may require multiple transfusions each week, this financial burden often deters individuals from accessing necessary hospice services. Therefore, the resolution aims to lessen the financial obstacles faced by patients and improve their overall end-of-life care experience.
Summary
House Resolution 76 (HR76) urges the Congress of the United States to implement policies that would enhance access to blood transfusions for hospice patients suffering from blood cancers, such as leukemia, lymphoma, and myeloma. The resolution highlights the critical need for these transfusions as an essential component of palliative care, aimed at improving comfort and quality of life for patients at the end of life, rather than extending their lifespan. It contends that due to misconceptions regarding the nature of blood transfusions and inadequate Medicare reimbursement, many patients do not seek appropriate hospice care, leading to excessive hospital treatments and diminished end-of-life quality.
Sentiment
The sentiment surrounding HR76 seems largely supportive within the context of healthcare advocacy, particularly among medical professionals and stakeholders who recognize the necessity of making blood transfusions accessible for hospice patients. There is a shared belief that enhancing these services will lead to better end-of-life care outcomes. However, challenges remain regarding public awareness and potential legislative inertia at the federal level, indicating a need for ongoing advocacy to ensure this change is prioritized and achieved.
Contention
Notably, the resolution aims to address not only the reimbursement fixes but also the wider perceptions of blood transfusions beyond simply being viewed as potential life-prolonging treatments. The contention lies in effectively communicating the importance of blood transfusions as a genuine palliative measure. By framing this discussion within the larger context of hospice care, HR76 seeks to foster an understanding that supports patient autonomy and dignity in end-of-life decision-making, and to advocate for structural policy changes that can lead to better care for those with serious health conditions.
"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes advanced life support providers, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for such providers.
Providing for patient election for donation and use of autologous blood; providing for disclosure of vaccination status in blood transfusions and requiring informed consent; and imposing duties on the Department of Health.
Requiring health care facilities to provide autologous blood transfusions and direct allogeneic blood transfusions to individuals under certain circumstances.
Establishes that the council on human blood and transfusion services shall review all current medical research and guidance regarding the donation of blood by patients with a history of Lyme or tick-borne illnesses.
Requiring health care facilities to provide autologous blood transfusions and direct allogeneic blood transfusions to individuals under certain circumstances.
"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes advanced life support providers, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for such providers.
Providing for patient election for donation and use of autologous blood; providing for disclosure of vaccination status in blood transfusions and requiring informed consent; and imposing duties on the Department of Health.